Enflonsia in Sri Lanka
How patients in Sri Lanka access Enflonsia (fentanyl transdermal class) via Named Patient Program.
Enflonsia - overview
Enflonsia (fentanyl transdermal class) is manufactured by TBD – verify and indicated for Chronic pain — OUT OF SCOPE (fentanyl class / Schedule II; PlatformCo does not handle controlled substances. Product-name mapping also uncertain — verify FDA label before any future consideration by Fatima's entity.). It is a unverified approved by the US FDA in unverified and may be accessible to patients in Sri Lanka through a Named Patient Program or personal-import pathway.
Access in Sri Lanka
Sri Lanka's NMRA permits named-patient import for rare-disease specialty drugs via physician request.
How Reserve Meds coordinates access in Sri Lanka
- Patient or treating physician submits a request.
- We verify clinical appropriateness and Sri Lanka-specific eligibility.
- Treating physician in Sri Lanka issues prescription and clinical justification.
- Country-specific NPP/personal-import forms are prepared and filed.
- We source Enflonsia from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Sri Lanka.
Typical timeline for Sri Lanka
End-to-end, most requests are completed in 2-6 weeks. Sri Lanka's tier 3 regulatory maturity typically supports longer processing times.
What patients and physicians in Sri Lanka ask
- Is the pathway legal in Sri Lanka? Yes - it operates under Sri Lanka's established NPP or personal-import framework.
- Does my insurance cover it? Typically no for NPP drugs; patient prepayment is standard.
- What physician credentials do I need? A licensed physician in Sri Lanka able to issue the prescription and clinical justification.
- What if the drug is in shortage? We will inform you upfront and decline rather than promise what we cannot deliver.
- Can I re-supply? Yes - for chronic therapies we arrange ongoing re-supply.